Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial

NCT07361549 is registered in ClinicalTrials.gov with Daniel A Tonetti, MD as lead sponsor.

NCT NCT07361549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07361549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial
Lead sponsor
Daniel A Tonetti, MD
Phase
Phase 2
Overall status
Recruiting
Start date
September 9, 2026
Completion date
July 31, 2031
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache, refractory migraine